Skip to content

Prospective-randomized and double-blinded trial to evaluate the impact of a peritoneal flap on outcome and postoperative complications after robotic assisted radical prostatectomy (RARP) in patients with localized prostate cancer

Prospective-randomized and double-blinded trial to evaluate the impact of a peritoneal flap on outcome and postoperative complications after robotic assisted radical prostatectomy (RARP) in patients with localized prostate cancer - PIANOFORTE

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00011115
Enrollment
108
Registered
2016-12-08
Start date
2017-03-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C61 I89.8

Interventions

Group 1: Intervention Group - Patients undergoing RARP and treated with peritoneal flap additionally to standard OP procedure Group 2: Control Group - Patients undergoing RARP with standard OP procedu

Sponsors

St. Elisabeth- Klinikum Straubing, Urologische Klinik
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: - Obtained informed consent - Age > 18 years - local prostate cancer - planned RARP with pelvine lymph node dissection on both sides

Exclusion criteria

Exclusion criteria: - no informed consent (e.g. mental illness, communication Problems due to foreign language, etc.) - Patient lives more than 100 km away from Straubing - ASA > 3 - conversion from RARP to open radical prostatectomy

Design outcomes

Primary

MeasureTime frame
rate of postoperative lymphocele development

Secondary

MeasureTime frame
continence, vesico-urethral anastomose

Countries

Austria, Germany

Contacts

Public ContactGjoko Stojanoski

Klinik für Urologie, Klinikum St. Elisabeth Straubing

gjoko.stojanoski@klinikum-straubing.de09421 / 710 - 1701

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 27, 2026